BPC-157 and GHK-Cu are both studied for tissue repair — but through fundamentally different pathways and in different research domains. This comparison covers mechanism distinctions, research applications, and sourcing context for informed research planning.
| Dimension | BPC-157 | GHK-Cu |
|---|---|---|
| Peptide length | 15 amino acids | 3 amino acids + Cu²⁺ |
| Primary mechanism | VEGF angiogenesis + NO | Collagen synthesis + MMP modulation |
| Research domain | Musculoskeletal, GI tract | Dermatology, wound healing |
| Endogenous? | Yes (gastric protein fragment) | Yes (human plasma, declines with age) |
| Topical use studied? | Limited | Extensively (copper peptide serums) |
| Gene expression data | Limited transcriptomic data | 4,000+ genes modulated (Pickart data) |
BPC-157 is a 15–amino acid gastric peptide studied for VEGF-mediated angiogenesis and tissue repair in gut, tendon, and ligament models. GHK-Cu is a naturally occurring copper tripeptide studied for collagen synthesis, matrix metalloproteinase modulation, and dermatological applications. Different peptide sizes, origins, and primary research domains.